Arthur Flick, MD
Orthopaedic Surgery · Clayton, GANPI 1952435828
Payments from drug & device makers
Across 21 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shire North American Group Inc$74
- Daiichi Sankyo Inc.$35
- Melinta Therapeutics, LLC$32
- Nestle Healthcare Nutrition Inc.$31
- Lilly USA, LLC$26
- Vertex$23
- plus $113 from 7 others
What the payments were for
- Food & beverage$334100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shire North American Group Inc | 4 | $74 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Melinta Therapeutics, LLC | 2 | $32 |
| Nestle Healthcare Nutrition Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $26 |
| Vertex | 1 | $23 |
| Abbott | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Surmodics, Inc. | 2 | $18 |
| Boston Scientific | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Smith+Nephew | 1 | $11 |
How this compares
$334 in reported general payments places this provider in the 15th percentile of 654 orthopaedic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 576 | $14,236 |
| Oxycodone Hcl | 385 | $8,051 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $7,156 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 220 | $6,863 |
| Probenecid-ColchicineProbenecid/Colchicine | 48 | $1,968 |
| Cyclobenzaprine Hcl | 212 | $1,811 |
| Gabapentin | 184 | $1,764 |
| Clonazepam | 72 | $824 |
| Doxepin Hcl | 31 | $813 |
| Tramadol Hcl | 61 | $800 |
| CholestyramineCholestyramine (With Sugar) | 13 | $744 |
| Lidocaine | 13 | $636 |
| Buprenorphine Hcl | 15 | $622 |
| Alprazolam | 176 | $600 |
| Methocarbamol | 34 | $498 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Clayton
- Charles DecookCumming$48.3M
- Ormonde MahoneyAthens$10.8M
- Daxes BanitWarner Robins$5.7M
- John DorchakColumbus$3.8M
- Daniel SilcoxAtlanta$3.4M
- Dennis DevitoAtlanta$1.5M
- George GuildCumming$1.4M
- Jon MinterAlpharetta$1.4M
- Tuan BuiLawrenceville$1.1M
- William TallyAthens$870K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.